Cargando…
N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients
It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894446/ https://www.ncbi.nlm.nih.gov/pubmed/25778460 http://dx.doi.org/10.1038/srep09109 |
_version_ | 1782435679785975808 |
---|---|
author | Zong, Xiaofen Hu, Maolin Li, Zongchang Cao, Hongbao He, Ying Liao, Yanhui Zhou, Jun Sang, Deen Zhao, Hongzeng Tang, Jinsong Lv, Luxian Chen, Xiaogang |
author_facet | Zong, Xiaofen Hu, Maolin Li, Zongchang Cao, Hongbao He, Ying Liao, Yanhui Zhou, Jun Sang, Deen Zhao, Hongzeng Tang, Jinsong Lv, Luxian Chen, Xiaogang |
author_sort | Zong, Xiaofen |
collection | PubMed |
description | It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve FEP and 38 controls were enrolled in this study to explore the effect of 8-week risperidone monotherapy on NAA. All spectra were obtained from the medial prefrontal cortex (MPFC) on a 3.0 T MRI and analyzed with LCModel. At baseline, patients presented no significant differences in NAA (P = 0.084) or NAA/Cr + Pcr (P = 0.500) compared to controls; NAA levels were negatively correlated with PANSS total scores (P = 0.001) and WCST-PE (P = 0.041). After treatment, patients demonstrated significant reductions of NAA (P < 0.001) and NAA/Cr + Pcr (P < 0.001), and significant improvement in PANSS-P (P < 0.001) and PANSS-G (P < 0.001) symptoms. We detected no significant correlations between NAA alterations and PANSS-P (P = 0.679) or PANSS-G (P = 0.668) symptom changes; nor did NAA/Cr + Pcr changes with alterations in PANSS-P (P = 0.677) and PANSS-G (P = 0.616). This is the first evidence that short-term risperidone treatment induces an acute reduction of MPFC NAA during the early phase of schizophrenia, which may be a previously unavailable biomarker to indicate risperidone with a similar pharmacological mechanism, although the functional significance is still unclear. |
format | Online Article Text |
id | pubmed-4894446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48944462016-06-10 N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients Zong, Xiaofen Hu, Maolin Li, Zongchang Cao, Hongbao He, Ying Liao, Yanhui Zhou, Jun Sang, Deen Zhao, Hongzeng Tang, Jinsong Lv, Luxian Chen, Xiaogang Sci Rep Article It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve FEP and 38 controls were enrolled in this study to explore the effect of 8-week risperidone monotherapy on NAA. All spectra were obtained from the medial prefrontal cortex (MPFC) on a 3.0 T MRI and analyzed with LCModel. At baseline, patients presented no significant differences in NAA (P = 0.084) or NAA/Cr + Pcr (P = 0.500) compared to controls; NAA levels were negatively correlated with PANSS total scores (P = 0.001) and WCST-PE (P = 0.041). After treatment, patients demonstrated significant reductions of NAA (P < 0.001) and NAA/Cr + Pcr (P < 0.001), and significant improvement in PANSS-P (P < 0.001) and PANSS-G (P < 0.001) symptoms. We detected no significant correlations between NAA alterations and PANSS-P (P = 0.679) or PANSS-G (P = 0.668) symptom changes; nor did NAA/Cr + Pcr changes with alterations in PANSS-P (P = 0.677) and PANSS-G (P = 0.616). This is the first evidence that short-term risperidone treatment induces an acute reduction of MPFC NAA during the early phase of schizophrenia, which may be a previously unavailable biomarker to indicate risperidone with a similar pharmacological mechanism, although the functional significance is still unclear. Nature Publishing Group 2015-03-16 /pmc/articles/PMC4894446/ /pubmed/25778460 http://dx.doi.org/10.1038/srep09109 Text en Copyright © 2015, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zong, Xiaofen Hu, Maolin Li, Zongchang Cao, Hongbao He, Ying Liao, Yanhui Zhou, Jun Sang, Deen Zhao, Hongzeng Tang, Jinsong Lv, Luxian Chen, Xiaogang N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title | N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title_full | N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title_fullStr | N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title_full_unstemmed | N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title_short | N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients |
title_sort | n-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894446/ https://www.ncbi.nlm.nih.gov/pubmed/25778460 http://dx.doi.org/10.1038/srep09109 |
work_keys_str_mv | AT zongxiaofen nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT humaolin nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT lizongchang nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT caohongbao nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT heying nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT liaoyanhui nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT zhoujun nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT sangdeen nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT zhaohongzeng nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT tangjinsong nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT lvluxian nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients AT chenxiaogang nacetylaspartatereductioninthemedialprefrontalcortexfollowing8weeksofrisperidonetreatmentinfirstepisodedrugnaiveschizophreniapatients |